CoChat

The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial

Al Hamarneh, Yazid N., Hemmelgarn, Brenda R., Hassan, Imran, Jones, Charlotte A., Tsuyuki, Ross T. · 2017 · Canadian Journal of Diabetes
Cited by 36

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcjd.2017.08.244

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 21

  1. Diabetes Canada, 2013, 2013 clinical practice guidelines, Can J Diabetes, 37, S1
  2. Lam, 2015, Assessment of cardiovascular risk in diabetes: Risk scores and provocative testing, World J Diabetes, 6, 634, 10.4239/wjd.v6.i4.634 · DOI
  3. Grenier, 2016, Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: Insights from the diabetes mellitus status in Canada survey, Eur Heart J Qual Care Clin Outcomes, 2, 277, 10.1093/ehjqcco/qcw013 · DOI
  4. Shiu, 2006, Quantifying opportunities to affect diabetes management in the community, Can Pharm J, 139, 37
  5. Al Hamarneh, 2013, Pharmacist intervention for glycaemic control in the community (The RxING study), BMJ Open, 3, e003154, 10.1136/bmjopen-2013-003154 · DOI
  6. O'Donovan, 2011, The role of pharmacists in control and management of type 2 diabetes mellitus: A review of the literature, J Diabetol, 1, 5
  7. Wubben, 2008, Effects of pharmacist outpatient interventions on adults with diabetes mellitus: A systematic review, Pharmacotherapy, 28, 421, 10.1592/phco.28.4.421 · DOI · Paper page
  8. Armour, 2004, Implementation and evaluation of Australian pharmacists' diabetes care services, J Am Pharm Assoc, 44, 455, 10.1331/1544345041475625 · DOI
  9. Fornos, 2006, A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain, Pharm World Sci, 28, 65, 10.1007/s11096-006-9003-0 · DOI
  10. Krass, 2007, The pharmacy diabetes care program: Assessment of a community pharmacy diabetes service model in Australia, Diabet Med, 24, 677, 10.1111/j.1464-5491.2007.02143.x · DOI · Paper page
  11. Al Hamarneh, 2012, Glycemic control in community-dwelling patients with type 2 diabetes, Can Pharm J, 2, 68, 10.3821/145.2.cpj68 · doi:10.3821/145.2.cpj68
  12. Leiter, 2013, Type 2 diabetes mellitus management in Canada: Is it improving?, Can J Diabetes, 37, 82, 10.1016/j.jcjd.2013.02.055 · DOI
  13. Tsuyuki, 2016, Effectiveness of community pharmacist prescribing and care on cardiovascular risk reduction: Randomized controlled RxEACH trial, J Am CollCardiol, 67, 2846, 10.1016/j.jacc.2016.03.528 · DOI · Paper page
  14. Leung, 2016, Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension, Can J Cardiol, 32, 569
  15. Hackam, 2013, The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension, Can J Cardiol, 29, 528
  16. Anderson, 2013, 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult, Can J Cardiol, 29, 151
  17. Tobe, 2011, Harmonization of guidelines for the prevention and treatment of cardiovascular: The C-CHANGE initiative, CMAJ, 183, e1135, 10.1503/cmaj.101508 · DOI
  18. D'Agostino, 2008, General cardiovascular risk profile for use in primary care: The Framingham Heart Study, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579 · DOI · Paper page
  19. Wilson, 2012, An international model to predict recurrent cardiovascular disease, Am J Med, 125, 695, 10.1016/j.amjmed.2012.01.014 · DOI · Paper page
  20. Song, 2004, Coronary heart disease risk assessment in diabetes mellitus: Comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications, Diabet Med, 21, 238, 10.1111/j.1464-5491.2004.01116.x · DOI · Paper page
  21. Martinez, 2017, Frequency and impact of pharmacist interventions in clinical trial patients with diabetes, Clin Ther, 39, 714, 10.1016/j.clinthera.2017.02.006 · doi:10.1016/j.clinthera.2017.02.006

Cited by

See all 36

Metadata

Authors
Al Hamarneh, Y. N., Hemmelgarn, B. R., Hassan, I., Jones, C. A., & Tsuyuki, R. T.
Venue
Canadian Journal of Diabetes
Publisher
Elsevier BV
Published
2017-12
Volume
41
Issue
6
Pages
580-586
ISSN
1499-2671
Cited by
36
References
2
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • RxEACH-CKD: Alberta Health (RES0020309)
  • The Cardiovascular Health and Stroke Strategic Clinical Network of Alberta Health Services (RES0027161)
  • Merck Canada (RES0019426)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial. https://app.cochat.ai/papers/10.1016/j.jcjd.2017.08.244
The paper
Al Hamarneh, Y. N., Hemmelgarn, B. R., Hassan, I., Jones, C. A., & Tsuyuki, R. T. (2017). The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled RxEACH Trial. Canadian Journal of Diabetes. https://doi.org/10.1016/j.jcjd.2017.08.244

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.